Study Comparing a DTaP-HB-PRP~T Combined Vaccine With Tritanrix HepB/Hib™, Concomitantly With OPV in Healthy Infants

NCT00348881 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

2133

Enrollment

INDUSTRY

Sponsor class

Conditions

Diphtheria
Tetanus
Pertussis
Hepatitis B
Influenza

Interventions

BIOLOGICAL: DTaP-HB-PRP~T combined vaccine
BIOLOGICAL: Tritanrix-HepB/Hib™ vaccine
BIOLOGICAL: Oral poliomyelitis vaccine (OPV)

Sponsor

Sanofi Pasteur, a Sanofi Company